Search Results - "Lagadinou, E.D."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity by Callahan, K P, Minhajuddin, M, Corbett, C, Lagadinou, E D, Rossi, R M, Grose, V, Balys, M M, Pan, L, Jacob, S, Frontier, A, Grever, M R, Lucas, D M, Kinghorn, A D, Liesveld, J L, Becker, M W, Jordan, C T

    Published in Leukemia (01-10-2014)
    “…Identification of agents that target human leukemia stem cells is an important consideration for the development of new therapies. The present study…”
    Get full text
    Journal Article
  3. 3

    c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia by Lagadinou, E D, Ziros, P G, Tsopra, O A, Dimas, K, Kokkinou, D, Thanopoulou, E, Karakantza, M, Pantazis, P, Spyridonidis, A, Zoumbos, N C

    Published in Leukemia (01-10-2008)
    “…Chemotherapy resistance is a major challenge in acute myeloid leukemia (AML). Besides the P-glycoprotein efflux, additional cellular factors may contribute to…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6